Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison

ABSTRACT:

Background:

The coronavirus disease 2019 (COVID-19) pandemic was an unprecedented shock to the healthcare systems, and its consequences on managing rare cancers are unknown. We investigated COVID-19’s impact on the activity of sarcoma-labeled networks by comparing key indicators in 2019–2020 (before and during the pandemic, respectively).

Methods:

We compared the incidence of limb and trunk soft tissue sarcomas, surgery rate, surgery center, surgery quality, and surgery delays nationally and in various regions, focusing on the three most severely affected regions.

Findings:

In this study, sarcoma incidence did not decrease, and the tumor and patient characteristics were similar in both years. The number of patients who underwent surgery in the labeled centers inc

SUBMITTER:  

PROVIDER: S-EPMC10472827 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature